Acute ischemic hepatitis in aortocaval fistula

G Sobrinho1, M E Ferreira, J P Albino

  • 1Department of Vascular Surgery, Hospital de Santa Marta, Lisboa, Portugal. gsobrinho@netscape.net

Insights

Aortocaval fistula can cause acute ischemic hepatitis, marked by high liver enzymes and creatinine. This liver dysfunction is a common complication but benign, resolving after surgery.

Area of Science:

  • Vascular Surgery
  • Hepatology
  • Nephrology

Background:

  • Aortocaval fistula is a rare but serious complication.
  • Liver dysfunction can occur in patients with aortocaval fistula.
  • Characterizing this dysfunction is important for patient management.

Purpose of the Study:

  • To characterize liver dysfunction in patients with aortocaval fistula.
  • To assess the clinical course and outcomes of liver dysfunction associated with aortocaval fistula.

Main Methods:

  • Retrospective study of four patients operated on for aortocaval fistula.
  • Measurement of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), and creatinine.
  • Comparison with four control patients operated on for ruptured abdominal aortic aneurysm (AAA).

Main Results:

  • All patients with aortocaval fistula exhibited elevated AST, ALT, and LDH levels.
  • Peak liver enzyme and creatinine levels were observed in the early postoperative period.
  • Liver function markers normalized with recovery, and all patients survived.

Conclusions:

  • Acute ischemic hepatitis is a common complication of aortocaval fistula.
  • Liver dysfunction associated with aortocaval fistula has a benign course.
  • Successful surgical repair leads to full resolution of liver dysfunction.
Abstract